| ROCHE HLDG AG GEN. | 246.55 / +0.84% |
| Date/Time | 06/14 / 10:17 |
| Chg. / Chg.(%) | 2.05 / +0.84% |
| Bid | - |
| Ask | - |
| Open | 246.50 |
| Previous Close | 244.50 |
| High | 246.55 |
| Low | 246.50 |
| Volume [EUR] | 22,189.50 |
| Volume [Units] | 90 |
| Price fixings | 2 |
| ISIN | CH0012032048 |
| Security | RHO5 |
| Exchange | München |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| Lang & Schwa.. | 245.163 |  |
|
| SIX Swiss Ex.. | 276.00 | |
1,047,334 |
| Cboe Europe .. | 275.70 | |
141,847 |
| Cboe Europe .. | 275.65 | |
79,084 |
| London Inter.. | 276.04 | |
44,083 |
| Turquoise | 275.70 | |
29,986 |
| Xetra | 246.95 | |
6,956 |
| Stuttgart | 246.500 | |
2,677 |
| TradeGate | 246.000 | |
2,094 |
| Frankfurt | 246.700 | |
1,127 |
| München | 246.55 | |
90 |
| Nasdaq Other.. | 275.8000 | |
84 |
| Borsa Italia.. | 247.00 | |
19 |
| Berlin | 246.35 | |
16 |
| Düsseldorf | 246.20 | |
0 |
| Hamburg | 245.60 | |
0 |
| gettex | 246.200 | |
|
| Mexico | 5,346.69 | 42 | |
| Borsa Italia.. | 247.00 | ||
| EUREX | Options | ||
News
- UK watchdog to probe Roche-Spark merger
06/10/2019 / 08:41 - TeleTrader - DNA Sequencing Research, Applied and Clinical Markets, 2023
05/28/2019 / 16:07 - GlobeNewswire - Roche announces FDA approval for Venclexta plus Gazyva for people with previously untreated chronic lymphocytic leukaemia
05/16/2019 / 07:03 - GlobeNewswire - Roche's personalised medicine entrectinib shrank tumours harbouring NTRK, ROS1 or ALK gene fusions in children and adolescents
05/16/2019 / 07:00 - GlobeNewswire - New Roche test aids clinicians in accelerating tuberculosis diagnosis and treatment by detecting antimicrobial resistance within the world's leading cause of infectious disease deaths
05/14/2019 / 07:03 - GlobeNewswire
Real-time